Idebenone

Idebenone is a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. This has been met with limited success.

Idebenone

Idebenone; Idebenona; Idebenonum; CV 2619

Id-45, Ideben, Ideox, Norwayz

2-(12-hydroxydodecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione

NA

NA

NA

Prescribed for the treatment and management of Alzheimer’s disease, Friedreich's ataxia, mitochondrial encephalomyopathy and as a treatment for wrinkles in aesthetic practice.

NA

This drug interacts with CYP3A4, CYP2C19 and CYP1A2 (cytochrome P450 monooxygenase inhibitors).

Idebenone is contraindicated in patients with moderate to severe form of hepatic and renal impairments. 

Store below 30°C (86°F)

Molecular weight

366.498

Molecular formula

C21H34O5

CAS number

58186-27-9

Precautions

• Regular monitoring of blood counts and LFT is recommended.
• Discontinue if allergy develop with this drug.